APA (7th ed.) Citation

Gennatas, S., Stanway, S. J., Thomas, R., Min, T., Shah, R., O'Brien, M. E., & Popat, S. (2013). Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma. BMC Cancer, 13(1), 1. https://doi.org/10.1186/1471-2407-13-207

Chicago Style (17th ed.) Citation

Gennatas, Spyridon, Susana J. Stanway, Robert Thomas, Toon Min, Riyaz Shah, Mary E.R O'Brien, and Sanjay Popat. "Early Pneumothorax as a Feature of Response to Crizotinib Therapy in a Patient with ALK Rearranged Lung Adenocarcinoma." BMC Cancer 13, no. 1 (2013): 1. https://doi.org/10.1186/1471-2407-13-207.

MLA (9th ed.) Citation

Gennatas, Spyridon, et al. "Early Pneumothorax as a Feature of Response to Crizotinib Therapy in a Patient with ALK Rearranged Lung Adenocarcinoma." BMC Cancer, vol. 13, no. 1, 2013, p. 1, https://doi.org/10.1186/1471-2407-13-207.